ABBOTT LABORATORIES - Common Stock (ABT)

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / Common Stock
Shares outstanding
1,740,239,592
Total 13F shares
1,306,014,624
Share change
-811,271
Total reported value
$142,022,460,179
Put/Call ratio
105%
Price per share
$108.83
Number of holders
2,293
Value change
-$6,984,888
Number of buys
1,006
Number of sells
1,009

Institutional Holders of ABBOTT LABORATORIES - Common Stock (ABT) as of Q3 2020

As of 30 Sep 2020, ABBOTT LABORATORIES - Common Stock (ABT) was held by 2,293 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,306,014,624 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., Capital Research Global Investors, STATE STREET CORP, Capital International Investors, WELLINGTON MANAGEMENT GROUP LLP, NORTHERN TRUST CORP, BANK OF AMERICA CORP /DE/, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, and MORGAN STANLEY. This page lists 2,295 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.